HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hiroaki Itamochi Selected Research
Hiroaki Itamochi Research Topics
Disease
48
Neoplasms (Cancer)
11/2022 - 08/2002
27
Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 02/2002
23
Carcinoma (Carcinomatosis)
12/2021 - 01/2002
9
Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 12/2003
9
Ovarian Epithelial Carcinoma
12/2019 - 05/2004
6
Adenocarcinoma
12/2015 - 08/2002
4
Mucinous Adenocarcinoma (Mucinous Carcinoma)
12/2021 - 03/2009
4
Endometrial Neoplasms (Endometrial Cancer)
01/2020 - 08/2002
3
Infections
06/2016 - 02/2002
2
Neoplasm Metastasis (Metastasis)
09/2020 - 01/2018
2
Nausea
08/2019 - 11/2014
2
Vomiting
08/2019 - 11/2014
2
Disease Progression
07/2018 - 06/2006
2
Endometriosis
01/2015 - 06/2013
2
Breast Neoplasms (Breast Cancer)
11/2013 - 07/2005
1
Body Weight (Weight, Body)
01/2021
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
09/2020
1
Anorexia
08/2019
1
Malnutrition (Nutritional Deficiencies)
08/2019
1
Residual Neoplasm
06/2019
1
Endometrioid Carcinoma
06/2018
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018
1
Dyspnea (Shortness of Breath)
01/2018
1
Leiomyosarcoma
01/2018
1
Lymphedema (Milroy Disease)
06/2015
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2015
Drug/Important Bio-Agent (IBA)
17
Proteins (Proteins, Gene)
FDA Link
01/2020 - 02/2002
12
Platinum
IBA
01/2021 - 01/2002
11
Paclitaxel (Taxol)
FDA Link
Generic
11/2022 - 08/2002
11
Cisplatin (Platino)
FDA Link
Generic
10/2017 - 01/2002
6
Bevacizumab (Avastin)
FDA Link
11/2022 - 07/2010
6
Biomarkers (Surrogate Marker)
IBA
12/2020 - 07/2010
6
taxane
IBA
11/2014 - 07/2005
5
Carboplatin (JM8)
FDA Link
Generic
11/2022 - 06/2006
4
Phosphotransferases (Kinase)
IBA
01/2018 - 07/2005
4
TOR Serine-Threonine Kinases
IBA
03/2014 - 02/2010
3
RNA (Ribonucleic Acid)
IBA
01/2018 - 11/2013
3
Docetaxel (Taxotere)
FDA Link
01/2018 - 03/2004
3
Irinotecan (Camptosar)
FDA Link
Generic
10/2014 - 03/2012
3
Phosphatidylinositols (Phosphatidylinositol)
IBA
03/2014 - 12/2007
3
Antineoplastic Agents (Antineoplastics)
IBA
01/2014 - 06/2002
2
MicroRNAs (MicroRNA)
IBA
12/2020 - 02/2010
2
Chimeric Antigen Receptors
IBA
10/2017 - 01/2017
2
Integrins
IBA
10/2017 - 01/2017
2
Messenger RNA (mRNA)
IBA
01/2017 - 02/2008
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2017 - 02/2012
2
Indicators and Reagents (Reagents)
IBA
12/2015 - 08/2002
2
Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)
IBA
05/2015 - 06/2013
2
Drug Combinations
IBA
11/2014 - 01/2014
2
dactolisib
IBA
08/2014 - 03/2014
2
nedaplatin
IBA
01/2013 - 07/2012
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
10/2012 - 07/2010
2
ErbB Receptors (EGF Receptor)
IBA
10/2012 - 07/2010
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
10/2012 - 07/2010
2
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
07/2012 - 12/2007
2
2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- one
IBA
07/2012 - 12/2007
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
07/2012 - 12/2007
2
Retinoids
IBA
12/2008 - 02/2008
1
pembrolizumab
IBA
11/2022
1
niraparib
IBA
01/2021
1
Nivolumab
IBA
09/2020
1
Sunitinib (Sutent)
FDA Link
09/2020
1
N-(2-chloro-4-pyridyl)-N'-phenylurea
IBA
01/2020
1
Cytokinins
IBA
01/2020
1
Dual Specificity Phosphatase 6
IBA
12/2019
1
Long Noncoding RNA
IBA
06/2019
1
rho GTP-Binding Proteins (rho GTP-Binding Protein)
IBA
06/2019
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2018
1
Gemcitabine
FDA Link
01/2018
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2018
1
Gold Sodium Thiomalate (Sodium Aurothiomalate)
IBA
11/2017
1
Aurora Kinase A
IBA
10/2017
1
Keratins (Keratin)
IBA
04/2017
1
Vimentin
IBA
04/2017
1
Thyroglobulin
FDA Link
01/2017
1
Cadherins (E-Cadherin)
IBA
01/2017
1
Topotecan (Hycamtin)
FDA Link
Generic
10/2016
1
farletuzumab
IBA
01/2016
1
Paraffin
IBA
12/2015
1
SERPIN-B5 (maspin)
IBA
12/2015
1
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
12/2015
1
Threonine (L-Threonine)
FDA Link
09/2015
1
Proteome
IBA
09/2015
1
Cytidine Diphosphate (CDP)
IBA
06/2015
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
05/2015
Therapy/Procedure
30
Drug Therapy (Chemotherapy)
11/2022 - 01/2002
15
Therapeutics
12/2021 - 02/2002
6
Hysterectomy
09/2020 - 06/2004
4
Lymph Node Excision (Lymph Node Dissection)
10/2016 - 06/2004
3
Neoadjuvant Therapy
10/2016 - 04/2014
3
Combination Drug Therapy (Combination Chemotherapy)
10/2016 - 03/2009
1
Nephrectomy
09/2020
1
Radiofrequency Therapy
01/2018
1
Immunotherapy
01/2017
1
Operative Surgical Procedures
10/2016
1
Trachelectomy
10/2016
1
Minimally Invasive Surgical Procedures
10/2016
1
Aftercare (After-Treatment)
06/2016
1
Activities of Daily Living (ADL)
06/2015